Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
BWX Technologies
BWXT
$15.4B
| $572K | ﹤0.01% |
10,388
+5,040
| +94% | +$262K |
|
2677
HCI Group
HCI
$2.28B
| $572K | ﹤0.01% |
8,438
-486
| -5% | -$32.1K |
|
2678
VanEck Agribusiness ETF
MOO
$971M
| $572K | ﹤0.01% |
6,618
| – | – |
|
2679
Melco Resorts & Entertainment
MLCO
$2.19B
| $570K | ﹤0.01% |
99,101
-3,550
| -3% | -$20.8K |
|
2680
RB Global
RBA
$17.8B
| $569K | ﹤0.01% |
8,745
+6,733
| +335% | +$395K |
|
2681
Sony
SONY
$132B
| $568K | ﹤0.01% |
34,755
+370
| +1% | +$6.55K |
|
|
NEWR
2682
DELISTED
New Relic, Inc.
NEWR
| $565K | ﹤0.01% |
11,302
+10,130
| +864% | +$562K |
|
2683
Commault Systems
CVLT
$5.52B
| $563K | ﹤0.01% |
8,954
-3,481
| -28% | -$216K |
|
2684
iShares US Consumer Discretionary ETF
IYC
$1.22B
| $563K | ﹤0.01% |
+9,919
| New | +$641K |
|
2685
Hecla Mining
HL
$11.1B
| $560K | ﹤0.01% |
142,770
-233,035
| -62% | -$1.21M |
|
|
ILPT
2686
Industrial Logistics Properties Trust
ILPT
$584M
| $560K | ﹤0.01% |
39,752
-62,654
| -61% | -$1.03M |
|
|
OPLN
2687
Openlane
OPLN
$4.05B
| $559K | ﹤0.01% |
37,889
-59,051
| -61% | -$926K |
|
2688
City Holding Co
CHCO
$2.06B
| $557K | ﹤0.01% |
6,974
-17,268
| -71% | -$1.37M |
|
2689
ESCO Technologies
ESE
$8.49B
| $555K | ﹤0.01% |
8,117
-12,770
| -61% | -$834K |
|
2690
Veracyte
VCYT
$3.71B
| $555K | ﹤0.01% |
27,861
-5,630
| -17% | -$114K |
|
2691
Meridian
MRBK
$236M
| $554K | ﹤0.01% |
36,538
| – | – |
|
|
DCPH
2692
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $554K | ﹤0.01% |
42,148
-138,226
| -77% | -$1.53M |
|
2693
Newmark Group
NMRK
$2.77B
| $550K | ﹤0.01% |
56,826
+28,627
| +102% | +$331K |
|
2694
TechTarget
TTGT
$321M
| $550K | ﹤0.01% |
8,370
-12,897
| -61% | -$899K |
|
2695
Dyne Therapeutics
DYN
$4.89B
| $547K | ﹤0.01% |
79,499
+60,313
| +314% | +$415K |
|
2696
Madrigal Pharmaceuticals
MDGL
$11.9B
| $547K | ﹤0.01% |
7,639
-1,676
| -18% | -$123K |
|
|
CVGW
2697
DELISTED
Calavo Growers
CVGW
| $546K | ﹤0.01% |
13,095
-7,526
| -36% | -$273K |
|
2698
EVgo
EVGO
$216M
| $545K | ﹤0.01% |
90,710
+29,235
| +48% | +$278K |
|
|
BMAQ
2699
DELISTED
Blockchain Moon Acquisition Corp. Common Stock
BMAQ
| $544K | ﹤0.01% |
55,000
-50,000
| -48% | -$494K |
|
|
UCTT
2700
Ultra Clean Holdings
UCTT
$3.6B
| $542K | ﹤0.01% |
18,200
-21,904
| -55% | -$711K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 561 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 561 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.